Becton, Dickinson and Company (BDX)
Makes syringes, needles, and diagnostic devices for hospitals and laboratories worldwide
$158.92+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+14.6%
The outlook
BDX is trading above its long-term moving averages with a solidly bullish analyst consensus leaning toward Buy. The stock sits roughly midway in its 52-week range, with the average analyst price target about 13% above the current price. The trailing P/E of 27.8 reflects a premium valuation for this healthcare equipment and supplies company.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 11 analysts
Price trendAbove its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Price targetAvg target +13% vs current price
Analyst price target
~12-month · 11 analysts$179.36average target+12.9% vs now
Now $158.92
Low $161.00High $225.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
$187.35
52-wk low
$127.59
50-day avg
$149.88
200-day avg
$154.70
Trailing P/E
27.8